Skip to content
Screener

Discontinued — last reported Q2 '26

Total Revenue at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$4.98B-9.5%
TFX
TeleflexTFX
$570.33M+28.9%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$1.08B+7.9%
IAR
Integra LifeSciencesIART
$418.76M+0.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$381.88M+7.5%
PDE
Pro-Dex, Inc.PDEX
$19.95M+14.6%

Segments

By product

See full
Gynecology/Electrosurgery/Urology$4.28M-11.0%
Neonatal$1.92M-8.7%
Blood Pressure Monitoring and Accessories$1.26M-37.4%
Obstetrics$1.07M+4.0%

By geography

See full
Global$38.52M-5.8%
Ous$15.76M-9.7%

Other financials

Income statement

See full
Gross profit$4.8M-15.0%
Operating income$2.6M-17.1%
Net income$2.7M-11.9%
EPS (diluted)$0.84-10.6%

Balance sheet

See full
Cash & equivalents$87.5M+6.5%
Total debt$195.0K-23.8%
Total equity$122.0M+3.8%
Total assets$124.6M+3.1%

Cash flow

See full
Operating cash flow$1.4M-51.9%
CapEx$134.0K+163%
Free cash flow$1.2M-55.7%

Valuation

See full
Market cap$225.7M+14.9%
Enterprise value$138.37M+20.7%
P/E21.5×+5.9×
P/S6.3×+1.2×

Profitability

See full
Gross margin57.9%+0.6pp
Operating margin28.4%-4.1pp
Net margin29%-3.3pp
FCF margin31.7%-3.8pp

Returns & leverage

See full
Return on equity8.8%-1.6pp
Debt / equity0.0×
Current ratio48.6×+6.7×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Utah Medical Products’s 10-Q, filed August 12, 2026.

Filed
Aug 12, 2026, 1:57 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001096906-26-001210
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Sales, net$8,529$9,953$17,252$19,663
Cost of goods sold3,7714,3587,2128,530
Gross profit4,7585,59510,04011,133
Operating expense
Selling, general and administrative1,9552,2644,5174,495
Research & development154135308289
Total operating expenses2,1092,3994,8254,784
Operating income2,6493,1965,2156,349

Cover / Front Matter

FAQ

What is Utah Medical Products's total revenue?
Utah Medical Products (UTMD) reported total revenue of $8.53M in Q2 2026.
How has Utah Medical Products's total revenue changed year-over-year?
Utah Medical Products's total revenue decreased by 14.3% year-over-year, from $9.95M to $8.53M.
What is the long-term trend for Utah Medical Products's total revenue?
Over 4 years (2021 to 2025), Utah Medical Products's total revenue has grown at a -5.9% compound annual growth rate (CAGR), from $49.05M to $38.52M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Utah Medical Products's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude